La liste ci-dessous contient des informations sur les essais cliniques financés par Ipsen.
Seules les études interventionnelles qui ont débuté au cours des 20 dernières années et se sont achevées au cours des 2 dernières années seront affichées.
Les résultats de l’étude seront disponibles sur ClinicalTrials.gov à partir de 12 mois après la fin de l’étude.
Last Data Refreshed @ 15-May-2025 16:08:09 UTC
Filtres
Condition
Statut
Phase
Country
Showing : 1 – 5 de 163 clinical trials
Upper Limb Spasticity
Dysport
Australia
Not Yet Recruiting
Dummy study Ipsen.com 2025 with only EUDRACT
This is a test
1. line break
2. line break
Upper Limb Spasticity
Dysport
Austria
Not Yet Recruiting
Dummy study Ipsen.com 2025 with only EUCT
This is a test
1. line break
2. line break
Fibrodysplasia Ossificans Progressiva (FOP)
Sohonos
United States of America (the)
United Kingdom of Great Britain and Northern Ireland (the)
Brazil
France
Canada
Australia
Argentina
Italy
Spain
Sweden
Not Yet Recruiting
A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ?14 Years With Fibrodysplasia Ossificans Progressiva (FOP) Who Have Completed the Relevant Parent Studies.
The main objective of this study is to further evaluate the safety and efficacy of palovarotene in adult and paediatric participants with FOP. The aim of the study is also to ensure treatment continuity to participants who have completed one of the parent studies (Study PVO-1A-301, Study PVO-1A-202 and Study PVO-1A-204) and who, in the investigator’s judgement, may benefit from palovarotene therapy.
Indication Study X1
elafibranor
United States of America (the)
United Kingdom of Great Britain and Northern Ireland (the)
Italy
France
Gabon
Not Yet Recruiting
Public Title Study X1
Brief Summary study X1
Indication Study X1
elafibranor
United Kingdom of Great Britain and Northern Ireland (the)
United States of America (the)
Gabon
France
Italy
Not Yet Recruiting
Public Title Study X1
Brief Summary study X1